Interleukin-10 Inhibits Interleukin-12 P40 Gene Transcription by Targeting a Late Event in the Activation Pathway
Overview
Affiliations
Interleukin-10 (IL-10) is a potent anti-inflammatory cytokine that suppresses the induction of proinflammatory cytokine genes, including the IL-12 p40 gene. Despite considerable effort examining the effect of IL-10 on specific transcription factors and signaling molecules, the mechanism by which IL-10 inhibits gene transcription has remained elusive. To provide a different perspective to this problem, we examined the effect of IL-10 on molecular events occurring at the endogenous IL-12 p40 locus in lipopolysaccharide-stimulated peritoneal macrophages. IL-10 abolished recruitment of RNA polymerase II to the p40 promoter. However, it only modestly reduced binding of C/EBPbeta, as monitored by genomic footprinting and chromatin immunoprecipitation. It also had little effect on NF-kappaB complexes that are critical for p40 induction. A substantial reduction in nucleosome remodeling at the p40 promoter was observed, but the magnitude of this reduction appeared insufficient to account for the strong inhibition of transcription. Finally, a lipopolysaccharide-inducible DNase I hypersensitive site identified 10 kb upstream of the start site was unaffected by IL-10. Thus, despite a dramatic reduction in p40 transcription, several events required for activation of the endogenous p40 gene occurred relatively normally. These findings suggest that IL-10 blocks one or more events that occur after p40 locus decondensation and nucleosome remodeling and after, or in parallel with, the binding of a subset of p40 transcriptional activators.
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.
Kostecki K, Iida M, Crossman B, Salgia R, Harari P, Bruce J Cancers (Basel). 2024; 16(2).
PMID: 38254801 PMC: 10814769. DOI: 10.3390/cancers16020312.
Groft S, Nagy N, Boom W, Harding C Infect Immun. 2020; 89(1).
PMID: 33077627 PMC: 7927937. DOI: 10.1128/IAI.00323-20.
Reprogramming macrophage orientation by microRNA 146b targeting transcription factor IRF5.
Peng L, Zhang H, Hao Y, Xu F, Yang J, Zhang R EBioMedicine. 2016; 14:83-96.
PMID: 27825654 PMC: 5161420. DOI: 10.1016/j.ebiom.2016.10.041.
Clark S, Filak H, Guthrie B, Schmidt R, Jamieson A, Merkel P PLoS Pathog. 2016; 12(6):e1005708.
PMID: 27295349 PMC: 4905663. DOI: 10.1371/journal.ppat.1005708.
TNF Counterbalances the Emergence of M2 Tumor Macrophages.
Kratochvill F, Neale G, Haverkamp J, Van de Velde L, Smith A, Kawauchi D Cell Rep. 2015; 12(11):1902-14.
PMID: 26365184 PMC: 4581986. DOI: 10.1016/j.celrep.2015.08.033.